A placebo-controlled, double-blind trial of Benorylate tablets in the treatment of bursitis and synovitis due to sports injury.
In this two-week study, Benoral tablets, at a 4.5 g daily dosage were compared with a matching placebo in 20 patients suffering from sports injury. Four assessments were made: pain at rest, pain on movement, tenderness and soft tissue swelling. In each case the active treatment group (benorylate) was statistically greater than that in the placebo group at one week and after two weeks' treatment.
D001265:Athletic Injuries / Q000150:complications*; D002062:Bursitis / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D012459:Salicylates / Q000008:administration & dosage / Q000627:therapeutic use*; D013585:Synovitis / Q000188:drug therapy* / Q000209:etiology; D013607:Tablets
D010919:Placebos; D012459:Salicylates; D013607:Tablets